Latest Feature

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at De

Covidien's Stacy Enxing Seng speaks to about the Medtronic merger during our DeviceTalks Minnesota event.

FDA cybersecurity rejections are on the way

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Brian Walsh looks to transcend glaucoma treatment with CyPass micro-stent

Transcend Medical CEO Brian Walsh tells why his company's CyPass micro-stent is poised to revolutionize the treatment of glaucoma.

Subscribe to the MassDevice
Enter your email:

Need Medtech news in a minute? We Deliver!

MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Johnson & Johnson launches $5B buyback

July 22, 2014 by Arezu Sarvestani

Healthcare giant Johnson & Johnson plans to repurchase up to $5 billion of its own shares over an indefinite amount of time.

Johnson & Johnson buys back $5B shares

Johnson & Johnson (NYSE:JNJ) last night announced that its board of directors approved a $5 billion open-ended repurchase program for shares of the company's common stock.

Medtech saves the U.S. billions in chronic care, industry study says | On Call

July 22, 2014 by Arezu Sarvestani

A new AdvaMed-backed report from the Milken Institute finds that medical devices help save the U.S. billions in recurring care and lost economic activity. On Call

MASSDEVICE ON CALL — The medical device industry has been a target for years for researchers and critics who have claimed the industry is a prime contributor to the skyrocketing cost of U.S. healthcare, and industry advocates responded this month with a new study in the industry's defense.

Boston Scientific's bare-metal Rebel stent comes to the U.S.

July 21, 2014 by Arezu Sarvestani

Medtech titan Boston Scientific lands FDA approval for its Rebel bare-metal stent, made of the company's proprietary platinum chromium alloy.

Boston Scientific's bare-metal Rebel stent comes to the U.S.

Massachusetts medical device giant Boston Scientific (NYSE:BSX) today announced FDA approval for the latest in its line of coronary stents, the Rebel bare-metal stent.

Biolase launches $12M private placement amid internal turmoil, shares soar

July 21, 2014 by Arezu Sarvestani

Wall Street rallies as dental laser maker Biolase raises $12 million through a private placement round, even as the company deals with an ongoing civil war involving ousted CEO Federico Pignatelli.

Biolase launches $12M private placement

California-based Biolase (NSDQ:BIOL) announced today that it secured $12 million in a private placement funding round, even as the company weathers the internal tumult following the ouster of former CEO Federico Pignatelli.

Align Tech declares a 'total win' as federal circuit reverses ITC ruling

July 21, 2014 by Arezu Sarvestani

A new Federal Circuit Court ruling means Align Technology can move forward with a patent infringement case against rival ClearCorrect.

Align Tech declares a 'total win' as federal circuit reverses ITC ruling

Dental devices maker Align Technology (NSDQ:ALGN) touted a Federal Circuit Court ruling issued this month, calling it a "total win for Align." +3 | The top 3 medtech stories for July 21, 2014

July 21, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.


Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp